Natsuko Ohashi
Overview
Explore the profile of Natsuko Ohashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohgaku S, Ida S, Ohashi N, Morino K, Ishikado A, Yanagimachi T, et al.
Heliyon
. 2024 Aug;
10(14):e34490.
PMID: 39130439
Introduction: Endothelial cells have a crucial function in transporting and exchanging various nutrients. -GlcNAcylation, mediated by -GlcNAc transferase (OGT), involves the addition of -acetylglucosamine to proteins and serves as an...
2.
Kobayashi S, Morino K, Okamoto T, Tanaka M, Ida S, Ohashi N, et al.
Physiol Rep
. 2024 Jun;
12(11):e16047.
PMID: 38837588
Acetate is a short-chain fatty acid (SCFA) that is produced by microbiota in the intestinal tract. It is an important nutrient for the intestinal epithelium, but also has a high...
3.
Katagi M, Nakae Y, Okano J, Fujino K, Tanaka T, Miyazawa I, et al.
Biochem Biophys Res Commun
. 2023 Oct;
682:132-137.
PMID: 37806251
Bone marrow derived cells (BMDCs) migrate into the hypothalamus, where those cells give rise to microglia to regulate food intake. Given the fact that diabetes functionally impairs BMDCs, we hypothesized...
4.
Kitamura T, Terashima T, Katagi M, Ohashi N, Nozaki K, Tsuji A
Cytotherapy
. 2023 Aug;
25(11):1186-1199.
PMID: 37552144
Background Aims: Stroke is a frequently observed neurological disorder that might lead to permanent and severe disability. Recently, various regenerative therapies have been developed, some of which have already been...
5.
Kojima H, Katagi M, Okano J, Nakae Y, Ohashi N, Fujino K, et al.
Commun Biol
. 2023 Jun;
6(1):637.
PMID: 37311905
Despite the growing epidemic worldwide, diabetes is an incurable disease. We have been focusing on why diabetes manifests refractoriness to any therapy. We recently found that abnormal bone marrow-derived cells...
6.
Nakamoto A, Ohashi N, Sugawara L, Morino K, Ida S, Perry R, et al.
Am J Physiol Endocrinol Metab
. 2023 May;
325(1):E46-E61.
PMID: 37224467
Adipose tissues accumulate excess energy as fat and heavily influence metabolic homeostasis. -linked -acetylglucosamine (-GlcNAc) modification (-GlcNAcylation), which involves the addition of -acetylglucosamine to proteins by -GlcNAc transferase (Ogt), modulates...
7.
Terashima T, Katagi M, Ohashi N
Stem Cells Transl Med
. 2023 Mar;
12(4):215-220.
PMID: 36976582
Diabetic neuropathy is a major complication of diabetes mellitus that occurs during the early stages of the disease. Many pathogenic mechanisms are related and induced by hyperglycemia. However, even if...
8.
Zen R, Terashima T, Tsuji S, Katagi M, Ohashi N, Nobuta Y, et al.
Front Pediatr
. 2022 May;
10:883556.
PMID: 35601427
Background: The pathophysiology of neonatal hypoxic-ischemic encephalopathy (HIE) has been studied in several rodent models to develop novel treatments. Although it is well known that high ambient temperature results in...
9.
Nishimura K, Fujita Y, Ida S, Yanagimachi T, Ohashi N, Nishi K, et al.
Mol Metab
. 2022 Feb;
59:101458.
PMID: 35189429
Objective: The intestine is an important organ for nutrient metabolism via absorption and endocrine systems. Nutrients regulate O-GlcNAcylation, a post-translational modification of various proteins by O-GlcNAc transferase (OGT). We have...
10.
Horibe K, Morino K, Miyazawa I, Tanaka-Mizuno S, Kondo K, Sato D, et al.
Diabetes Res Clin Pract
. 2022 Feb;
186:109781.
PMID: 35181350
Aim: We aimed to determine whether SGLT2 inhibitor dapagliflozin treatment affects body composition and amino acid (AA) metabolism. Methods: Fifty-two overweight patients treated by oral antidiabetic agents were randomly assigned...